In a significant policy move, the United States Environmental Protection Agency (EPA) has announced its intention to classify microplastics and pharmaceuticals as contaminants in drinking water. This proposal marks a pivotal step in addressing the growing concerns surrounding the safety of drinking water for American families. The draft, which forms part of the agency’s Contaminant Candidate List, is now open for public comment and could lead to regulatory changes aimed at safeguarding public health.
New Contaminant Candidate List
On 2 April 2026, the EPA unveiled its draft of the sixth iteration of the Contaminant Candidate List, which identifies substances not currently regulated under the Safe Drinking Water Act. This latest proposal reflects a response to increasing public anxiety regarding the presence of microplastics and pharmaceutical residues in drinking water supplies. EPA Administrator Lee Zeldin emphasised the importance of water safety, stating, “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water.”
The inclusion of these contaminants is seen as a victory for advocacy groups, particularly the Maha movement spearheaded by health secretary Robert F. Kennedy Jr. The movement has pressed for more stringent measures against environmental pollutants, making the EPA’s announcement a critical first step towards enhanced regulatory oversight.
Health Implications of Microplastics and Pharmaceuticals
Research has indicated a concerning prevalence of microplastics in drinking water, as well as potential health impacts on human organs such as the heart and brain. The implications of these findings are still under investigation, but medical professionals express a growing alarm regarding the long-term effects of microplastic exposure. Additionally, pharmaceuticals often enter water supplies through human excretion, and many conventional wastewater treatment processes struggle to effectively eliminate these substances.
Judith Enck, a former EPA regional administrator, commented on the significance of the proposal, stating, “Including it in the list would be the first step toward eventually regulating microplastics in public water supplies and hopefully this is not the last step.” This sentiment highlights the need for continued advocacy and action to protect water quality.
The Regulatory Journey Ahead
The EPA’s Contaminant Candidate List serves as a framework for guiding research, funding, and regulatory decisions. However, the agency has historically been slow to advance from identifying to regulating pollutants. In March, the EPA announced it would not develop regulations for any of the nine contaminants recently examined, leading some to question the agency’s commitment to meaningful change. Erik Olson, a senior attorney at the Natural Resources Defense Council, remarked, “It’s the beginning of a very long process that routinely ends in nothing.”
Despite these challenges, there is cautious optimism among environmental advocates. The proposal to assess microplastics and pharmaceuticals is viewed as a necessary starting point. Dr Philip Landrigan, director of the Global Observatory on Planetary Health, stressed that while the EPA’s move is commendable, it must be accompanied by an overall reduction in plastic production to effectively combat pollution.
Collaborative Efforts for Change
The announcement from the EPA coincides with a growing alliance between the agency and Kennedy’s Maha movement, which has been vocal about environmental issues, including pesticide regulation and plastic pollution. Recently, the movement has expressed dissatisfaction with the pace of regulatory action but remains hopeful about future initiatives. The EPA is reportedly finalising a comprehensive agenda that will address “forever chemicals,” plastic pollution, food quality, and other pressing environmental concerns.
Kennedy has also launched a $144 million initiative called the Systematic Targeting of Microplastics (STOMP). This programme aims to develop tools for detecting microplastics, understanding their movement within the human body, and ultimately finding ways to eliminate them. “We can’t treat what we cannot measure. We cannot regulate what we don’t understand,” Kennedy stated, highlighting the urgency of addressing microplastic pollution.
Why it Matters
The EPA’s proposal to recognise microplastics and pharmaceuticals as drinking water contaminants is a critical step towards safeguarding public health and ensuring safer water supplies for communities across the United States. While the road to regulation may be fraught with challenges, this initiative signals a growing acknowledgment of the environmental crisis posed by plastic pollution. As advocacy groups, health professionals, and policymakers work together, the hope is that this momentum will lead to more robust protections and a sustainable future for drinking water safety.
